NCT05181553
- Conditions
- Cardiovascular Diseases, Cholesterol, Elevated, Cholesterol; Metabolic Disorder, +14 more
- Locations
-
- Institute on nutrition and functional foods, Laval University Québec, Quebec, Canada
Clinical trial condition
Hyperlipoproteinemias
Explore clinical trials studying Hyperlipoproteinemias. Study availability and eligibility vary by location and protocol.
231 public trials
40 recruiting studies
Hyperlipoproteinemias trial results
NCT06009393
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- The Second Xiangya Hospital of Central South University Hospital Changsha, Hunan, China
NCT04681170
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Universtiats-Kinderlinik Heidelberg Heidelberg, Baden-Wurttemberg, Germany
- University Hospital of Cologne Cologne, Germany
- University Medical Center Hamburg-Eppendorf Hamburg, Germany
- Chaim Sheba Medical Center Ramat Gan, Israel
Completed
Baby Detect : Genomic Newborn Screening
NCT05687474
- Conditions
- 3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
- Locations
-
- CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
NCT07023445
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
Completed
Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
NCT03110432
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Dyslipoproteinemias, +14 more
- Locations
-
- Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Germany
- Innere Medizin IV - Diabetologie, Endokrinologie und Nephrologie am Universitaetsklinikum Tübingen, Germany
- Nephrologisches Zentrum Villingen-Schwenningen, Germany
Completed
A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease
NCT05398029
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +16 more
- Locations
-
- Clinical Study Center Auckland, New Zealand
- Clinical Study Center Christchurch, New Zealand
- Clinical Study Center London, United Kingdom
NCT03409744
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Clinical Trial Site Los Angeles, California, United States
- Clinical Trial Site Boca Raton, Florida, United States
- Clinical Trial Site Boston, Massachusetts, United States
- Clinical Trial Site New York, United States
Completed
Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels
NCT06910098
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Central Park Teaching Hospital Lahore, Pakistan
Completed
Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia
NCT05611528
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Ecogene-21 Saguenay, Quebec, Canada